SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Dana-Farber Cancer Institute at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Dana-Farber Cancer Institute brings 14 presentations to SITC 2026 in Phoenix. Its program centres on cancer vaccines, from personalized vaccines to hidden tumor-only targets in the so-called dark proteome, alongside boosters for CAR T and NK cell therapies. One distinctive item engineers tumor-colonizing bacteria that stay in the tumor and steer immune cells to attack it.

OrganizationSITC 2026 Attendance
Cancer centres & hospitals
Harvard-affiliated cancer treatment and research center in Boston.
Workshop
Thu Nov 5
5:00pm–9:00pm
Launching Biotech Startups: Funding, Pitching, Partnerships
  1. 5:00pm–5:30pmWelcome Reception
  2. 5:40pm–6:40pmPharma Perspectives on External Innovation
  3. 6:45pm–7:20pmPanel: Pharma Perspectives on External Innovation
  4. 7:25pm–8:10pmPanel: Financing and Partnerships
  5. 8:10pm–9:00pmClosing Networking Reception
Session
Fri Nov 6
9:40am–11:45am
Thomas Waldmann Memorial Plenary Session: Cancer Vaccines, Current and Future
Vaccines
  1. 9:44am–10:04amDiscovery and Development of a Pancreatic Cancer RNA VaccineMemorial Sloan Kettering Cancer Center
  2. 10:04am–10:24amUpdates on Clinical Results from the AMPLIFY-7P Study of a Lymph Node-Targeted Kras VaccineScripps Research
  3. 10:24am–10:37amSpatial profiling identifies response-associated tumor-immune niches and treatment-induced remodeling with mRNA-4359 plus pembrolizumab in melanomaMass General Brigham Cancer Institute
  4. 10:37am–10:57amLearning from Checkpoint Blockade: Prioritizing Neoantigens and Shared Tumor Antigens for Cancer VaccinesUniversity of Toulouse
  5. 10:57am–11:10amInduction of anti-cancer immunity by immunopeptidome-guided personalized peptide vaccines in advanced solid tumor patientsUniversity Hospital Tübingen
  6. 11:10am–11:30amThe Cancer Dark Proteome: A Rich Source of Tumor-Selective Cryptic AntigensDana-Farber Cancer Institute
  7. 11:30am–11:45amFrom Tumor to Treatment: The Science and Clinical Delivery of Intismeran Autogene An INTerpath-001 investigator’s perspectiveFred Hutchinson Cancer Center
Session
Sat Nov 7
5:20pm–6:40pm
Oral Abstract Session 4
  1. 5:23pm–5:38pmStromal-directed synthetic CAR T circuits effectively treat solid tumors and protect against on-target off-tumor toxicityUCSF
  2. 5:38pm–5:53pmClassical secretion of IL-18 is associated with improved functionality in armored anti-mKRAS TCR-T cellsHospital of the University of Pennsylvania
  3. 5:53pm–6:08pmCD28 GLYCO-EDITING AUGMENTS CD8 T CELL:TUMOR CELL INTERACTION AND KILLINGNetherlands Cancer Institute
  4. 6:08pm–6:23pmCRISPR Screen Identifies SLC7A5 as a Therapeutic Target to Enhance NK-Mediated Cytotoxicity
  5. 6:23pm–6:38pmProgrammable tumor-colonizing bacteria function as locally retained immune cell engagers for solid tumorsDana-Farber Cancer Institute

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Dana-Farber Cancer Institute

Tell us what you sell and we’ll find the people at Dana-Farber Cancer Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction